Amitriptyline hydrochloride patient counseling information: Difference between revisions
Gerald Chi (talk | contribs) Created page with "__NOTOC__ {{Amitriptyline}} {{CMG}} == <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AMITRIPTYLINE HYDROCHLORIDE TABLET, FILM COATED [MYLAN I..." |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
== | ==Patient Counseling Information== | ||
====Information for Patients==== | |||
Prescribers or other health professionals should inform patients, their families, and their caregivers about the benefits and risks associated with treatment with amitriptyline and should counsel them in its appropriate use. A patient Medication Guide about “Antidepressant Medicines, Depression and other Serious Mental Illness and Suicidal Thoughts or Actions” is available for amitriptyline. The prescriber or health professional should instruct patients, their families, and their caregivers to read the Medication Guide and should assist them in understanding its contents. Patients should be given the opportunity to discuss the contents of the Medication Guide and to obtain answers to any questions they may have. The complete text of the Medication Guide is reprinted at the end of this document. | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AMITRIPTYLINE HYDROCHLORIDE TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e454fe56-0896-4d40-862c-95ef0fc0bc82#nlm34090-1 | publisher = | date = | accessdate = }}</ref> | Patients should be advised of the following issues and asked to alert their prescriber if these occur while taking amitriptyline. | ||
While on therapy with amitriptyline hydrochloride, patients should be advised to the possible impairment of mental and/or physical abilities required for the performance of hazardous tasks, such as operating machinery or driving a motor vehicle.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AMITRIPTYLINE HYDROCHLORIDE TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e454fe56-0896-4d40-862c-95ef0fc0bc82#nlm34090-1 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== |
Latest revision as of 02:15, 10 February 2014
Amitriptyline |
---|
AMITRIPTYLINE HYDROCHLORIDE® FDA Package Insert |
Indications and Usage |
Dosage and Administration |
Contraindications |
Warnings and Precautions |
Adverse Reactions |
Drug Interactions |
Use in Specific Populations |
Overdosage |
Description |
Clinical Pharmacology |
How Supplied/Storage and Handling |
Patient Counseling Information |
Labels and Packages |
Clinical Trials on Amitriptyline |
ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Patient Counseling Information
Information for Patients
Prescribers or other health professionals should inform patients, their families, and their caregivers about the benefits and risks associated with treatment with amitriptyline and should counsel them in its appropriate use. A patient Medication Guide about “Antidepressant Medicines, Depression and other Serious Mental Illness and Suicidal Thoughts or Actions” is available for amitriptyline. The prescriber or health professional should instruct patients, their families, and their caregivers to read the Medication Guide and should assist them in understanding its contents. Patients should be given the opportunity to discuss the contents of the Medication Guide and to obtain answers to any questions they may have. The complete text of the Medication Guide is reprinted at the end of this document.
Patients should be advised of the following issues and asked to alert their prescriber if these occur while taking amitriptyline.
While on therapy with amitriptyline hydrochloride, patients should be advised to the possible impairment of mental and/or physical abilities required for the performance of hazardous tasks, such as operating machinery or driving a motor vehicle.[1]
References
Adapted from the FDA Package Insert.